BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2909490)

  • 1. Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.
    Whiting JL; Rosten PM; Chow AW
    Infect Immun; 1989 Jan; 57(1):231-4. PubMed ID: 2909490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
    Kunstmann G; Schröder E; Hasbach H; Pulverer G
    Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
    Jacobson JA; Kasworm E; Daly JA
    Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Clin Microbiol; 1986 Jun; 23(6):1138-9. PubMed ID: 3711305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of toxic shock syndrome in children with staphylococcal infection.
    Jacobson JA; Kasworm EM; Reiser RF; Bergdoll MS
    Am J Med Sci; 1987 Dec; 294(6):403-7. PubMed ID: 3425588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
    Bonventre PF; Weckbach L; Harth G; Haidaris C
    Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lethal, non-menstrual toxic shock syndrome associated with Staphylococcus aureus sepsis].
    Raumanns J; Kaufhold A; Behrendt W; Peters G
    Anaesthesist; 1995 Dec; 44(12):869-74. PubMed ID: 8594962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
    Lee VT; Chang AH; Chow AW
    J Infect Dis; 1992 Oct; 166(4):911-5. PubMed ID: 1527429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of serum antibodies to toxic-shock-syndrome-toxin-1 and to staphylococcal enterotoxins A, B and C in West-Germany.
    Schröder E; Kunstmann G; Hasbach H; Pulverer G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):110-4. PubMed ID: 3223132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
    Parsonnet J; Gillis ZA; Pier GB
    J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.
    Marples RR; Wieneke AA
    Epidemiol Infect; 1993 Jun; 110(3):477-88. PubMed ID: 8519313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic responses to toxic shock syndrome (TSS) toxin-1 in menstrual and nonmenstrual TSS.
    Rosten PM; Bartlett KH; Chow AW
    Clin Invest Med; 1988 Jun; 11(3):187-92. PubMed ID: 3402105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of staphylococcal superantigens.
    Salgado-Pabón W; Case-Cook LC; Schlievert PM
    Methods Mol Biol; 2014; 1085():169-85. PubMed ID: 24085696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments.
    See RH; Adilman S; Bartlett KH; Chow AW
    J Clin Microbiol; 1989 Sep; 27(9):2050-3. PubMed ID: 2778069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Toxic Shock Syndrome-Associated
    Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
    Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
    Quan L; Morita R; Kawakami S
    Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin.
    Stolz SJ; Davis JP; Vergeront JM; Crass BA; Chesney PJ; Wand PJ; Bergdoll MS
    J Infect Dis; 1985 May; 151(5):883-9. PubMed ID: 3989322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.